B
Bio-Rad Laboratories
Bio-Rad | Products for Life Science Research & Clinical Diagnostics
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostics markets. The company serves academic institutions, pharmaceutical companies, biotechnology firms, and clinical laboratories. Bio-Rad operates in the highly competitive life sciences and diagnostics markets, offering products that include reagents, instruments, and software for cell biology, gene expression, protein purification, and imaging. The business model focuses on selling these products directly to customers through a dedicated sales force and online platforms, generating revenue through product sales and service contracts. Bio-Rad's commitment to quality and innovation helps researchers and clinicians advance their discoveries and improve patient outcomes.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1952
- Headquarters
- Hercules, United States
- Listing
- IPO 1980
- Employees
- 9,410
- Open positions
- 113
- Dealroom signal
- 36.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Diabetes, Biotechnology, DNA, Genetics and genomics, observatoire healthtech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 13 companies, latest Feb 2026
- Capital deployed
- $123M
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Feb 2024 | $200M | — | Citibank · JP Morgan · Wells Fargo Securities | ↗ |
| POST IPO DEBT✓Debt | Mar 2022 | $1.2B | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Bio-Rad Laboratories is 690K monthly website visits, up 30.2% over the last three months. Bio-Rad Laboratories's team grew 4.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Oncocyte CorporationNashville, United StatesPrecision diagnostics for oncology and transplant monitoring
→
AfyniaHamilton, CanadaEndometriosis tests
$20Mvaluation
Stilla TechnologiesVillejuif, FranceBiotechnology company that focuses on accelerating the development of next-generation genetic tests
$225Mvaluation
OncoCyteNashville, United StatesFocused on cancers with large patient populations and significant unmet need
$113Mvaluation
GeneoscopyMaryland Heights, United StatesGeneoscopy is developing a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples
$420Mvaluation
Curiosity Diagnostics Sp z.o.o.Warsaw, PolandPCR One – Help when you need it most
→
Celsee DiagnosticsPlymouth, United StatesInnovative single-cell analysis solutions for advancing life sciences research and diagnostics
$32Mvaluation
Osler DiagnosticsOxford, United KingdomA ground-breaking handheld diagnostic for testing a vast range of biomarkers
$392Mvaluation
GnuBIOCambridge, United StatesDeveloper of scalable dna sequencing technology for the diagnostic and applied markets
$50Mvaluation
AbD SerotecRaleigh, United StatesA world leading antibody manufacturer supplying antibodies, kits and accessories
$58Mvaluation
QuantaLifePleasanton, United StatesProducts and services for the life science research and clinical diagnostic markets
$162Mvaluation
DiaMed Holding AGCressier, SwitzerlandImmunohematology, Infectious Disease Testing, QC, Microbiology, Diabetes & Autoimmune Testing
$393Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
JP Morgan
Citibank
Wells Fargo Securities
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bio-Rad Laboratories on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bio-Rad Laboratories’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





